Evidence map›Paper›PMID 31939323›Full record

Observational studyThe Journal of international medical research2020

Infusion of chimeric antigen receptor T cells against dual targets of CD19 and B-cell maturation antigen for the treatment of refractory multiple myeloma.

Fang Tang, Yin Lu, Yongqin Ge, Jingjing Shang, Xiaming Zhu

Open access · goldAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Multi-targeted immunotherapeutics to treat B cell malignancies.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Review
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Fang TangDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Yin LuDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Yongqin GeDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Jingjing ShangDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Xiaming ZhuDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.ORCID https://orcid.org/0000-0001-7430-6238
Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAntigens, CD19B-Cell Maturation AntigenCytokine Release SyndromeDrug Resistance, NeoplasmFemaleHumansImmunotherapy, AdoptiveIncidenceInfusions, IntravenousMaleMiddle AgedMultiple MyelomaReceptors, Chimeric AntigenT-LymphocytesTreatment OutcomeAntigens, CD19B-Cell Maturation AntigenCD19 molecule, humanReceptors, Chimeric AntigenTNFRSF17 protein, humanB-cell maturation antigenBCMA-refractory multiple myelomaCD19Chimeric antigen receptor T cellinflammatory factortemperature

Identifiers

PMID31939323
PMCPMC7114292
OpenAlexW2999134110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.